Related Experiment Videos
Decoding thyroid: liver cross talk in type 2 diabetes mellitus-an MASLD perspective
Sowmiya Subramani1, S Gayathri1, Karpagavel Lakshmanan1
1Department of Biochemistry, Chettinad Hospital and Research Institute(CHRI), CARE, Kelambakkam, Chengalpattu District, Tamil Nadu 603103 India.
Thyroid hormone resistance, indicated by higher FT3/FT4 and TFQIFT3, is linked to Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) in euthyroid adults. Insulin resistance may play a role in this association.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Hepatology
Background:
- Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) is a growing global health concern linked to metabolic abnormalities.
- Thyroid hormones are crucial for lipid metabolism and energy balance.
- This study investigates thyroid hormone resistance, not just levels, in MASLD development.
Purpose of the Study:
- To assess the relationship between thyroid hormone sensitivity indices and MASLD in euthyroid adults with Type 2 Diabetes Mellitus (T2DM).
Main Methods:
- 534 euthyroid T2DM participants were analyzed.
- Thyroid hormone sensitivity was measured using indices like FT3/FT4 ratio, TT3RI, TT4RI, TSHI, TFQIFT3, and TFQIFT4.
- Regression analyses evaluated associations between indices and MASLD.
Main Results:
- MASLD prevalence increased with higher FT3/FT4 ratio, TT3RI, and TFQIFT3.
- Elevated FT3/FT4 and TFQIFT3 were independent risk factors for MASLD after adjusting for confounders.
- The association was stronger in participants aged ≤40 years and partially mediated by the TyG index.
Conclusions:
- Higher FT3/FT4 and TFQIFT3 levels are strongly associated with MASLD prevalence in euthyroid individuals.
- The TyG index partially mediates the link between thyroid hormone sensitivity and MASLD, indicating a role for insulin resistance.
Related Concept Videos
Type II Diabetes I: Introduction
Hypothyroidism II: Pathophysiology
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis